Irina Rivkind Koffler
Stock Analyst
(n/a)
# 4,476
Out of 4,479 analysts
18
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EGRX Eagle Pharmaceuticals | Maintains: Neutral | n/a | $5.23 | - | 2 | Mar 22, 2019 | |
| EOLS Evolus | Maintains: Buy | n/a | $10.66 | - | 2 | Mar 19, 2019 | |
| PCRX Pacira BioSciences | Downgrades: Underperform | n/a | $22.74 | - | 2 | Feb 1, 2019 | |
| SUPN Supernus Pharmaceuticals | Maintains: Buy | n/a | $25.77 | - | 2 | Dec 17, 2018 | |
| TEVA Teva Pharmaceutical | Maintains: Buy | n/a | $16.55 | - | 5 | Sep 17, 2018 | |
| IRWD Ironwood Pharmaceuticals | Upgrades: Buy | n/a | $6.22 | - | 2 | May 2, 2018 | |
| DERM Journey Medical | Downgrades: Neutral | n/a | $5.24 | - | 2 | Mar 6, 2018 | |
| JAZZ Jazz Pharmaceuticals | Downgrades: Neutral | n/a | $105.09 | - | 1 | Apr 6, 2017 |
Eagle Pharmaceuticals
Mar 22, 2019
Maintains: Neutral
Price Target: n/a
Current: $5.23
Upside: -
Evolus
Mar 19, 2019
Maintains: Buy
Price Target: n/a
Current: $10.66
Upside: -
Pacira BioSciences
Feb 1, 2019
Downgrades: Underperform
Price Target: n/a
Current: $22.74
Upside: -
Supernus Pharmaceuticals
Dec 17, 2018
Maintains: Buy
Price Target: n/a
Current: $25.77
Upside: -
Teva Pharmaceutical
Sep 17, 2018
Maintains: Buy
Price Target: n/a
Current: $16.55
Upside: -
Ironwood Pharmaceuticals
May 2, 2018
Upgrades: Buy
Price Target: n/a
Current: $6.22
Upside: -
Journey Medical
Mar 6, 2018
Downgrades: Neutral
Price Target: n/a
Current: $5.24
Upside: -
Jazz Pharmaceuticals
Apr 6, 2017
Downgrades: Neutral
Price Target: n/a
Current: $105.09
Upside: -